JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Myers, K. J.
Right arrow Articles by Baker, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Myers, K. J.
Right arrow Articles by Baker, B.

Vol. 304, Issue 1, 411-424, January 2003

Antisense Oligonucleotide Blockade of Tumor Necrosis Factor-alpha in Two Murine Models of Colitis

Kathleen J. Myers, Sreekant Murthy, Anne Flanigan, Donna R. Witchell, Madeline Butler, Susan Murray, Andrew Siwkowski, Deborah Goodfellow, Karen Madsen and Brenda Baker

Isis Pharmaceuticals, Carlsbad, California (K.J.M., D.R.W., M.B., Su.M., A.S., D.G., B.B.); MCP Hahnemann University, Philadelphia, Pennsylvania (Sr.M., A.F.); and University of Alberta, Edmonton, Alberta, Canada (K.M.)

Tumor necrosis factor-alpha (TNF-alpha ) is a key cytokine involved in the pathogenesis of inflammatory bowel disease. We have developed a second-generation antisense oligonucleotide (ISIS 25302) specific for murine TNF-alpha and have evaluated this oligonucleotide in two models of gut inflammation of distinct etiology. ISIS 25302 decreased TNF-alpha mRNA in a dose- and sequence-dependent manner in vitro in the mouse macrophage cell line P388D1. It also reduced TNF-alpha mRNA in vivo, in whole adipose tissue and in macrophages isolated from the adipose tissue of db/db mice, a strain with constitutively high expression of TNF-alpha . ISIS 25302 significantly reduced disease activity index scores in mice with both an acute and a chronic form of dextran sodium sulfate (DSS)-induced colitis. It also significantly improved histopathological scores in interleukin (IL)-10-deficient mice. This was accompanied by reductions in both the basal and lipopolysaccharide-stimulated secretion of TNF-alpha and interferon-gamma in colonic organ cultures from IL-10 -/- mice. In this model, efficacy was obtained with both a prophylactic treatment regimen or a therapeutic dosing protocol begun after colitis was already present. In both the DSS and IL-10 -/- models, scrambled and mismatch control oligonucleotides were largely without effect, suggesting that ISIS 25302 was exerting its effects through a sequence-dependent antisense mechanism.

0022-3565/03/3041-0411$07.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2003 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Onizawa, T. Nagaishi, T. Kanai, K.-i. Nagano, S. Oshima, Y. Nemoto, A. Yoshioka, T. Totsuka, R. Okamoto, T. Nakamura, et al.
Signaling pathway via TNF-{alpha}/NF-{kappa}B in intestinal epithelial cells may be directly involved in colitis-associated carcinogenesis
Am J Physiol Gastrointest Liver Physiol, April 1, 2009; 296(4): G850 - G859.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
P. Buanne, E. Di Carlo, L. Caputi, L. Brandolini, M. Mosca, F. Cattani, L. Pellegrini, L. Biordi, G. Coletti, C. Sorrentino, et al.
Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice
J. Leukoc. Biol., November 1, 2007; 82(5): 1239 - 1246.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Kohno, R. Suzuki, Y. Yasui, S. Miyamoto, K. Wakabayashi, and T. Tanaka
Ursodeoxycholic Acid versus Sulfasalazine in Colitis-Related Colon Carcinogenesis in Mice
Clin. Cancer Res., April 15, 2007; 13(8): 2519 - 2525.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
C. G De Vry, S. Prasad, L. Komuves, C. Lorenzana, C. Parham, T. Le, S. Adda, J. Hoffman, N. Kahoud, R. Garlapati, et al.
Non-viral delivery of nuclear factor-{kappa}B decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis
Gut, April 1, 2007; 56(4): 524 - 533.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. Fujii, C. Zhu, Y. Wen, H. Marusawa, B. Bailly-Maitre, S.-i. Matsuzawa, H. Zhang, Y. Kim, C. F. Bennett, W. Jiang, et al.
HBXIP, Cellular Target of Hepatitis B Virus Oncoprotein, Is a Regulator of Centrosome Dynamics and Cytokinesis.
Cancer Res., September 15, 2006; 66(18): 9099 - 9107.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
D. J. Law, E. M. Labut, R. D. Adams, and J. L. Merchant
An isoform of ZBP-89 predisposes the colon to colitis
Nucleic Acids Res., March 3, 2006; 34(5): 1342 - 1350.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
D Gao, A H Wagner, S Fankhaenel, T Stojanovic, S Schweyer, S Panzner, and M Hecker
CD40 antisense oligonucleotide inhibition of trinitrobenzene sulphonic acid induced rat colitis
Gut, January 1, 2005; 54(1): 70 - 77.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.